1. Home
  2. BIO vs OLED Comparison

BIO vs OLED Comparison

Compare BIO & OLED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • OLED
  • Stock Information
  • Founded
  • BIO 1952
  • OLED 1985
  • Country
  • BIO United States
  • OLED United States
  • Employees
  • BIO N/A
  • OLED N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • OLED Semiconductors
  • Sector
  • BIO Industrials
  • OLED Technology
  • Exchange
  • BIO Nasdaq
  • OLED Nasdaq
  • Market Cap
  • BIO 7.7B
  • OLED 7.4B
  • IPO Year
  • BIO N/A
  • OLED 1992
  • Fundamental
  • Price
  • BIO $286.05
  • OLED $140.22
  • Analyst Decision
  • BIO Strong Buy
  • OLED Strong Buy
  • Analyst Count
  • BIO 4
  • OLED 7
  • Target Price
  • BIO $333.50
  • OLED $190.43
  • AVG Volume (30 Days)
  • BIO 227.8K
  • OLED 583.1K
  • Earning Date
  • BIO 10-29-2025
  • OLED 10-29-2025
  • Dividend Yield
  • BIO N/A
  • OLED 1.32%
  • EPS Growth
  • BIO N/A
  • OLED 9.88
  • EPS
  • BIO 11.49
  • OLED 5.12
  • Revenue
  • BIO $2,554,200,000.00
  • OLED $661,991,000.00
  • Revenue This Year
  • BIO $2.12
  • OLED $6.28
  • Revenue Next Year
  • BIO $2.90
  • OLED $10.49
  • P/E Ratio
  • BIO $24.56
  • OLED $26.58
  • Revenue Growth
  • BIO N/A
  • OLED 6.23
  • 52 Week Low
  • BIO $211.43
  • OLED $103.70
  • 52 Week High
  • BIO $387.99
  • OLED $215.90
  • Technical
  • Relative Strength Index (RSI)
  • BIO 52.89
  • OLED 49.34
  • Support Level
  • BIO $276.49
  • OLED $133.63
  • Resistance Level
  • BIO $286.52
  • OLED $138.50
  • Average True Range (ATR)
  • BIO 7.83
  • OLED 4.09
  • MACD
  • BIO -2.03
  • OLED -0.05
  • Stochastic Oscillator
  • BIO 39.68
  • OLED 48.69

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About OLED Universal Display Corporation

Universal Display Corp researches, develops, and manufactures organic light-emitting diode, or OLED, technologies for use in displays for mobile phones, tablets, televisions, wearables, personal computers, automotive interiors, and the solid-state lighting market. OLED technologies are an alternative to light-emitting diode, or LED, technologies, in the solid-state lighting market, and liquid crystal displays in the flat-panel-display market. The Company has one reportable business segment being OLED technologies and materials. A large majority of the firm's revenue is generated in South Korea, with the rest coming from Japan, China, the United States, and other countries across the world.

Share on Social Networks: